An editorial is presented which addresses the author's views about advertising restrictions on cannabis products that are used for nonmedical purposes, and it mentions another article which appears in the same issue of the journal and deals with the legal aspects of cannabis and advertising in the U.S. America's Food and Drug Administration (FDA), the nation's Controlled Substances Act (CSA), and marijuana laws in places such as Oregon are assessed.
© 2001-2024 Fundación Dialnet · Todos los derechos reservados